During its August meeting, the European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) concluded 2 referrals and approved the list of participants
On 29 June, the European Commission adopted a new plan to tackle the rising threat from antimicrobial resistance (AMR) in the human and veterinary sector. In Europe,
Advocates of vaping claim it has helped in reducing the rate of smoking however they were left outraged when claims of smoking reduction made no mention of vapour products.
Experts are raising fresh concerns that metal-on-metal hip implants are leaching toxic chemicals into the blood, causing serious health complications. Doctors are being urged
Since 2011, the MHRA has been monitoring cases of a rare type of cancer in women fitted with breast implants. Experts have now called for a ban on the common breast implant
Following a public consultation held by the MHRA, antimalarial tablets have been reclassified as over the counter (OTC) medicines and can now be purchased at pharmacies
In January, April and May of this year, our newsletters highlighted the ongoing controversy with the vaginal mesh implants both in the USA and here in the UK. These devices
Falsified and substandard medicines have become a worldwide menace in the recent past. In January 2012, 100 people died after receiving substandard medication during treatment
The EMA has decided to include patients and consumers under the age of 18 in the activities of its scientific committees and working parties. The EMA believes this patient
The EMA maybe getting too close to the pharmaceutical companies it regulates, thus losing its impartiality. This is the concern raised by the watchdog tasked with